vs

Side-by-side financial comparison of F5, Inc. (FFIV) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $811.7M, roughly 1.8× F5, Inc.). ResMed runs the higher net margin — 27.6% vs 18.2%, a 9.4% gap on every dollar of revenue. On growth, F5, Inc. posted the faster year-over-year revenue change (11.0% vs 11.0%). Over the past eight quarters, F5, Inc.'s revenue compounded faster (8.0% CAGR vs 7.9%).

F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

FFIV vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.8× larger
RMD
$1.4B
$811.7M
FFIV
Growing faster (revenue YoY)
FFIV
FFIV
+0.0% gap
FFIV
11.0%
11.0%
RMD
Higher net margin
RMD
RMD
9.4% more per $
RMD
27.6%
18.2%
FFIV
Faster 2-yr revenue CAGR
FFIV
FFIV
Annualised
FFIV
8.0%
7.9%
RMD

Income Statement — Q2 FY2026 vs Q4 FY2026

Metric
FFIV
FFIV
RMD
RMD
Revenue
$811.7M
$1.4B
Net Profit
$148.0M
$392.6M
Gross Margin
81.4%
61.8%
Operating Margin
22.1%
34.6%
Net Margin
18.2%
27.6%
Revenue YoY
11.0%
11.0%
Net Profit YoY
1.5%
13.9%
EPS (diluted)
$2.58
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIV
FFIV
RMD
RMD
Q2 26
$1.4B
Q1 26
$811.7M
Q4 25
$822.5M
$1.4B
Q3 25
$810.1M
$1.3B
Q2 25
$780.4M
$1.3B
Q1 25
$731.1M
$1.3B
Q4 24
$766.5M
$1.3B
Q3 24
$746.7M
$1.2B
Net Profit
FFIV
FFIV
RMD
RMD
Q2 26
$392.6M
Q1 26
$148.0M
Q4 25
$180.1M
$392.6M
Q3 25
$190.5M
$348.5M
Q2 25
$189.9M
$379.7M
Q1 25
$145.5M
$365.0M
Q4 24
$166.4M
$344.6M
Q3 24
$165.3M
$311.4M
Gross Margin
FFIV
FFIV
RMD
RMD
Q2 26
61.8%
Q1 26
81.4%
Q4 25
81.5%
61.8%
Q3 25
82.2%
61.5%
Q2 25
81.0%
60.8%
Q1 25
80.7%
59.3%
Q4 24
81.7%
58.6%
Q3 24
80.8%
58.6%
Operating Margin
FFIV
FFIV
RMD
RMD
Q2 26
34.6%
Q1 26
22.1%
Q4 25
26.0%
34.6%
Q3 25
25.4%
33.4%
Q2 25
25.2%
33.7%
Q1 25
21.7%
33.0%
Q4 24
26.8%
32.5%
Q3 24
25.6%
31.6%
Net Margin
FFIV
FFIV
RMD
RMD
Q2 26
27.6%
Q1 26
18.2%
Q4 25
21.9%
27.6%
Q3 25
23.5%
26.1%
Q2 25
24.3%
28.2%
Q1 25
19.9%
28.3%
Q4 24
21.7%
26.9%
Q3 24
22.1%
25.4%
EPS (diluted)
FFIV
FFIV
RMD
RMD
Q2 26
$2.68
Q1 26
$2.58
Q4 25
$3.10
$2.68
Q3 25
$3.25
$2.37
Q2 25
$3.25
$2.58
Q1 25
$2.48
$2.48
Q4 24
$2.82
$2.34
Q3 24
$2.79
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIV
FFIV
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.4B
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$3.6B
$6.3B
Total Assets
$6.5B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIV
FFIV
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.2B
$1.4B
Q3 25
$1.3B
$1.4B
Q2 25
$1.4B
$1.2B
Q1 25
$1.3B
$932.7M
Q4 24
$1.2B
$521.9M
Q3 24
$1.1B
$426.4M
Total Debt
FFIV
FFIV
RMD
RMD
Q2 26
$663.8M
Q1 26
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Stockholders' Equity
FFIV
FFIV
RMD
RMD
Q2 26
$6.3B
Q1 26
$3.6B
Q4 25
$3.5B
$6.3B
Q3 25
$3.6B
$6.1B
Q2 25
$3.5B
$6.0B
Q1 25
$3.3B
$5.5B
Q4 24
$3.2B
$5.3B
Q3 24
$3.1B
$5.2B
Total Assets
FFIV
FFIV
RMD
RMD
Q2 26
$8.5B
Q1 26
$6.5B
Q4 25
$6.3B
$8.5B
Q3 25
$6.3B
$8.3B
Q2 25
$6.1B
$8.2B
Q1 25
$5.9B
$7.6B
Q4 24
$5.9B
$7.1B
Q3 24
$5.6B
$7.2B
Debt / Equity
FFIV
FFIV
RMD
RMD
Q2 26
0.11×
Q1 26
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIV
FFIV
RMD
RMD
Operating Cash FlowLast quarter
$525.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIV
FFIV
RMD
RMD
Q2 26
Q1 26
$525.1M
Q4 25
$159.2M
$339.7M
Q3 25
$208.1M
$457.3M
Q2 25
$282.2M
$538.8M
Q1 25
$256.6M
$578.7M
Q4 24
$202.8M
$308.6M
Q3 24
$246.5M
$325.5M
Free Cash Flow
FFIV
FFIV
RMD
RMD
Q2 26
Q1 26
Q4 25
$149.5M
$311.2M
Q3 25
$191.9M
$414.4M
Q2 25
$273.7M
$508.2M
Q1 25
$246.1M
$557.9M
Q4 24
$194.7M
$288.0M
Q3 24
$240.4M
$307.7M
FCF Margin
FFIV
FFIV
RMD
RMD
Q2 26
Q1 26
Q4 25
18.2%
21.9%
Q3 25
23.7%
31.0%
Q2 25
35.1%
37.7%
Q1 25
33.7%
43.2%
Q4 24
25.4%
22.5%
Q3 24
32.2%
25.1%
Capex Intensity
FFIV
FFIV
RMD
RMD
Q2 26
Q1 26
Q4 25
1.2%
2.0%
Q3 25
2.0%
3.2%
Q2 25
1.1%
2.3%
Q1 25
1.4%
1.6%
Q4 24
1.1%
1.6%
Q3 24
0.8%
1.5%
Cash Conversion
FFIV
FFIV
RMD
RMD
Q2 26
Q1 26
3.55×
Q4 25
0.88×
0.87×
Q3 25
1.09×
1.31×
Q2 25
1.49×
1.42×
Q1 25
1.76×
1.59×
Q4 24
1.22×
0.90×
Q3 24
1.49×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons